B6.Cg-Tg(Cebpb-rtTA2S*S2)1Bjd/Cnrm

Status

Available to order

EMMA IDEM:00404
International strain nameB6.Cg-Tg(Cebpb-rtTA2S*S2)1Bjd/Cnrm
Alternative namerTALAP-1
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Cebpb-rtTA2S*S2)1Bjd
Gene/Transgene symbolTg(Cebpb-rtTA2S*S2)1Bjd

Information from provider

ProviderHermann Bujard
Provider affiliationZentrum für Molekulare Biologie Heidelberg- ZMBH
Genetic informationTransgenic rTALAP-1 mice contain a transcription unit consisting of the liver-enriched activating protein (LAP or Cebpb) promoter region which extends to nt 2800, and a synthetic gene encoding the rtTA2S-S2 transactivator variant (Urlinger et al., Proc Natl Acad Sci USA ,2000), followed by the beta-globin intron/poly(A) sequence.
Phenotypic informationExpression of the rtTA2S-S2 transactivator variant (Urlinger et al., Proc Natl Acad Sci USA, 2000), followed by the beta-globin intron/poly(A) sequence.
References
  • Stringent doxycycline dependent control of CRE recombinase in vivo.;Schönig Kai, Schwenk Frieder, Rajewsky Klaus, Bujard Hermann, ;2002;Nucleic acids research;30;e134; 12466566
  • Use of the tetracycline system for inducible protein synthesis in the kidney.;Gallagher Anna Rachel, Schönig Kai, Brown Nelson, Bujard Hermann, Witzgall Ralph, ;2003;Journal of the American Society of Nephrology : JASN;14;2042-51; 12874458
  • Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity.;Urlinger S, Baron U, Thellmann M, Hasan M T, Bujard H, Hillen W, ;2000;Proceedings of the National Academy of Sciences of the United States of America;97;7963-8; 10859354
  • Pathogenetic mechanisms of amyloid A amyloidosis.;Simons J Paul, Al-Shawi Raya, Ellmerich Stephan, Speck Ivana, Aslam Samrina, Hutchinson Winston L, Mangione Palma P, Disterer Petra, Gilbertson Janet A, Hunt Toby, Millar David J, Minogue Shane, Bodin Karl, Pepys Mark B, Hawkins Philip N, ;2013;Proceedings of the National Academy of Sciences of the United States of America;110;16115-20; 23959890
  • Tissue-specific expression of ferritin H regulates cellular iron homoeostasis in vivo.;Wilkinson John, Di Xiumin, Schönig Kai, Buss Joan L, Kock Nancy D, Cline J Mark, Saunders Thomas L, Bujard Hermann, Torti Suzy V, Torti Frank M, ;2006;The Biochemical journal;395;501-7; 16448386

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Literature references

  • Stringent doxycycline dependent control of CRE recombinase in vivo.;Schönig Kai, Schwenk Frieder, Rajewsky Klaus, Bujard Hermann, ;2002;Nucleic acids research;30;e134; 12466566
  • Use of the tetracycline system for inducible protein synthesis in the kidney.;Gallagher Anna Rachel, Schönig Kai, Brown Nelson, Bujard Hermann, Witzgall Ralph, ;2003;Journal of the American Society of Nephrology : JASN;14;2042-51; 12874458
  • Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity.;Urlinger S, Baron U, Thellmann M, Hasan M T, Bujard H, Hillen W, ;2000;Proceedings of the National Academy of Sciences of the United States of America;97;7963-8; 10859354
  • Pathogenetic mechanisms of amyloid A amyloidosis.;Simons J Paul, Al-Shawi Raya, Ellmerich Stephan, Speck Ivana, Aslam Samrina, Hutchinson Winston L, Mangione Palma P, Disterer Petra, Gilbertson Janet A, Hunt Toby, Millar David J, Minogue Shane, Bodin Karl, Pepys Mark B, Hawkins Philip N, ;2013;Proceedings of the National Academy of Sciences of the United States of America;110;16115-20; 23959890
  • Tissue-specific expression of ferritin H regulates cellular iron homoeostasis in vivo.;Wilkinson John, Di Xiumin, Schönig Kai, Buss Joan L, Kock Nancy D, Cline J Mark, Saunders Thomas L, Bujard Hermann, Torti Suzy V, Torti Frank M, ;2006;The Biochemical journal;395;501-7; 16448386

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).